Today: 3 June 2026
Medibank share price drops after results — dividend lift, premium hike and what investors watch next
19 February 2026
1 min read

Medibank share price drops after results — dividend lift, premium hike and what investors watch next

Sydney, Feb 19, 2026, 18:13 (AEDT) — After-hours

  • Medibank ended the day off 6.2% following its half-year results release.
  • The interim dividend’s up 6.4%, now at 8.3 Australian cents per share, fully franked.
  • Premiums climbed in April, putting a spotlight back on member growth and claims expenses.

Shares of Medibank Private Ltd dropped 6.2% on Thursday, closing at A$4.50. The insurer surrendered some of the previous session’s gains as investors digested its half-year results.

Medibank reported that underlying net profit after tax, which excludes investment market swings, edged down 0.3% to A$297.8 million for the six months to Dec. 31. The board, though, bumped up the interim dividend by 6.4% to 8.3 Australian cents per share, fully franked—so it comes with local tax credits. “We’ve delivered on our growth commitments,” Chief Executive David Koczkar said, highlighting stronger momentum in health insurance and the expansion of the group’s health services business.

The numbers drop just as health insurers brace for April’s price reset, after Canberra approved an average 4.41% hike in private health insurance premiums starting April 1. The government also plans to ban “product phoenixing”—a tactic where insurers shutter a product only to relaunch a near-duplicate at a steeper price. Health, Disability and Ageing

Medibank will lift its premiums by an average of 5.10% starting April 1, following the green light from the government. That’s higher than the industry average.

Medibank’s investor presentation showed group operating profit climbing 6% to A$381.7 million. Health Insurance operating profit edged up 3.5% to A$361.5 million; profits in the Medibank Health segment jumped 28.5% to A$48.3 million. Net resident policyholder numbers increased by 38,300 over the year. The company also highlighted its acquisition of Better Medical for A$163.5 million, signaling a deeper move into primary care.

Top-line gains didn’t filter through everywhere. Net investment income slid 17.1% to A$94.9 million. Medibank also pointed to A$15.0 million in one-off cybercrime expenses linked to the 2022 breach—covering security upgrades plus legal and regulatory costs.

That marked a shift from Wednesday. Back then, Australian media had reported gains for health insurers like Medibank and NIB Holdings following the premium approvals.

NIB plans to hike its health insurance premiums by an average of 5.47% starting April 1.

Medibank’s underlying net profit for the first half landed at roughly A$298 million, coming in 2% to 4% shy of forecasts, according to Citi’s Nigel Pittaway. He pointed to softer returns from the private health insurance division and rising expenses.

There’s a risk here: larger premium hikes could draw fresh attention to value for money, nudging cost-conscious customers to switch plans or exit entirely, even as hospital and medical expenses keep rising. Throw in any additional cyber charges or negative regulatory news, and that would drag on sentiment, too.

Now attention turns to broker updates and potential tweaks to FY26 forecasts before Medibank’s interim dividend dates come up. Shares go ex-dividend Feb. 26, with the payout scheduled for March 18.

Latest articles

Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Lags Nasdaq, Turnaround Pressure Rises

3 June 2026
Snap Inc. shares slid 1.5% to $5.76 Tuesday—about 45% below last July’s high—even as the broader market rose, spotlighting investor doubts about Snap’s turnaround despite first-quarter revenue growth, narrowed losses, and major cost cuts; ad growth remains sluggish and the upcoming Specs update on June 16 is seen as a key test for future revenue momentum.
INFQ back on radar after UK quantum push; shares jump

INFQ back on radar after UK quantum push; shares jump

3 June 2026
Infleqtion shares surged 12.4% to $19.87 in late New York trading after announcing Gold Sponsorship of Quantum Fringe 2026 and new U.K. quantum partnerships, as investors bet on government contracts and expanded manufacturing, despite a $30.3 million quarterly net loss and warnings of ongoing operating losses if public-sector funding slows.
Corning shares move after AI news

Corning shares move after AI news

3 June 2026
Corning soared 13.4% to $200.40 on heavy volume after Nvidia’s CEO spotlighted the need for optical links in AI data centers, with Corning’s recent Nvidia and Meta deals making it a top play on AI infrastructure; first-quarter core sales jumped 18% and optical sales surged 36%, but investors face risks from consumer electronics demand and execution on new factory expansions.
Quantum computing stocks face a holiday week after IonQ stake filing and a Rigetti downgrade

IonQ Stock Jumped Again. A Giant Quantum IPO Is Putting the Trade on Trial

3 June 2026
IonQ shares closed up 3.1% at $71.40 before slipping 1.3% after hours as traders positioned ahead of Quantinuum’s upsized IPO, which seeks up to $1.46 billion at a $14.3 billion valuation; IonQ’s Q1 revenue surged 755% to $64.7 million with a raised 2026 outlook, but a $271.5 million operating loss and guidance for continued high expenses highlight risks as Wall Street awaits new sector benchmarks.
Xos Surges After Hours as Data-Center Power Play Hits Tape

Xos Surges After Hours as Data-Center Power Play Hits Tape

3 June 2026
Xos shares soared 135.8% to $5.26 in after-hours trading after launching a 2.5MWh Power Hub for data centers facing grid delays, but the company warned of "substantial doubt" about its ability to continue as a going concern, with just $9.8 million in cash at March 31 and no large orders yet announced for the new product.
Northern Star shares tick up with gold stocks as traders eye US inflation data
Previous Story

Northern Star shares tick up with gold stocks as traders eye US inflation data

Pro Medicus share price rebounds 5% as ASX:PME steadies after selloff — what to watch next week
Next Story

Pro Medicus share price rebounds 5% as ASX:PME steadies after selloff — what to watch next week

Go toTop